Rocket Pharma stocks cardiac gene therapies through $53 million acquisition of Renovacor

Gene therapy developer Rocket Pharmaceuticals is on track to gain FDA approval for its pioneering program, but it’s also interested in preserving its pipeline inventory. The company agreed to Acquisition of Renovacora biotechnology working to develop a gene therapy for a form of hereditary heart failure. According to financial terms announced Tuesday, the all-share transaction … Read more

Cigna Extends Coverage of Brainsway’s Brain Stimulator to Treat OCD

Obsessive-compulsive disorder (OCD) It was Rank by World Health Organization As one of the 10 most debilitating medical conditions in terms of income loss and reduced quality of life. The condition is complex and presents differently in each patient, and many of them are drug-resistant. These challenges make treating OCD difficult. Many patients with this … Read more

How many steps do you really need to take each day, according to science?

picture: Lyubko Smokovsky (stock struggle) The more you walk, the lower your risk of all-cause and cancer deaths, According to a new study, with benefits settled once you reach 10,000 steps per day. It is clear then that this is the number of steps we should aim for – or is it? Studies comparing health … Read more

Chronic deficiency of exercise associated with HFpEF

A chronic lack of exercise – termed ‘exercise deficiency’ – is associated with cardiac atrophy, decreased cardiac output and chamber size, and decreased cardiorespiratory fitness (CRF) in a subgroup of patients with heart failure With preserved ejection fraction (HFpEF), researchers say. They suggest that increasing the levels of physical activity for these sedentary individuals could … Read more